Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01336881 · ClinicalTrials.gov registry record
Biomarkers in Tissue Samples From Young Patients With Liver Cancer
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 99
- Enrollment target
NCT01336881: Completed study, sponsored by Children's Oncology Group.
NCT01336881 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01336881 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
This research trial is studying biomarkers in tissue samples from young patients with liver cancer. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
Interventions
- GENETIC gene expression analysis
- GENETIC microarray analysis
- GENETIC RNA analysis
- OTHER diagnostic laboratory biomarker analysis
- GENETIC nucleic acid sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2011-04 |
What the finished NCT01336881 record still lists
NCT01336881 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT01336881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01336881 about?
NCT01336881 is a clinical study titled "Biomarkers in Tissue Samples From Young Patients With Liver Cancer". This research trial is studying biomarkers in tissue samples from young patients with liver cancer. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
What is the current status of trial NCT01336881?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2011-04.
What interventions are being tested in trial NCT01336881?
The interventions under investigation include: gene expression analysis (GENETIC), microarray analysis (GENETIC), RNA analysis (GENETIC), diagnostic laboratory biomarker analysis (OTHER), nucleic acid sequencing (GENETIC).
Who is sponsoring clinical trial NCT01336881?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia